PUBLICATIONS
Filter Publications By:
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index (A-HIPI): Development and Validation of a Clinical Prediction Model from the HoLISTIC Consortium
Rodday AM, Parsons SK, Friedberg JW, Gallamini A, Hawkes E, Hodgson DC, Johnson P, Link BK, Mou E, Savage KJ, Upshaw J, Zinzani PL, Maurer MJ, Evens AM.
Journal of Clinical Oncology. 2022 Dec 10. DOI: 10.1200/JCO.22.02473
First-line Treatment in Older Patients With Hodgkin Lymphoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare Population-Based Study.
Rodday AM, Hahn T, Kumar AJ, Lindenauer PK, Friedberg JW, Evens AM, Parsons SK.
British J Haematol. 2020 Feb 23 doi: 10.1111/bjh.16525. Online ahead of print. PMID: 32090325.
Early-stage hodgkin lymphoma in the modern era: simulation modeling to delineate long-term patient outcomes.
Parsons SK, Kelly MJ, Cohen JT, Catellino SM, Henderson TO, Kelly KM, Keller FG, Henzer TJ, Kumar AJ, Johnson P, Meyer RM, Radford J, Raemaekers J, Hodgson DC, Evens AM.
British J Haematol. 2018 Jul;182(2):212-221. PMID 29707774. PMCID PMC6055753.
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis.
Henderson TO, Parsons SK, Wroblewski KE, Chen L, Hong F, Smith SM, McNeer JL, Advani RH, Gascoyne RD, Constine LS, Horning S, Bartlett NL, Shah B, Connors JM, Leonard JI, Kahl BS, Kelly KM, Schwartz CL, Li H, Friedberg JW, Friedman DL, Gordon LI, Evens AM
Cancer. 2018 Jan 1;124(1):136-144. PMID: 28902390. PMCID: PMC5735034.